Showing results (361-370 of 392) with videos related to

Sort By:
Pageof 40
Nature Communications|November 13, 2024
Cognitive reserve against Alzheimer's pathology is linked to brain activity during memory formationNiklas Vockert, Judith Machts, Luca Kleineidam, et al.
Alzheimer'S Research & Therapy|March 14, 2023
Exploring the ATN classification system using brain morphologyNils Heinzinger, Anne Maass, David Berron, et al.
Brain : a Journal of Neurology|May 14, 2024
Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuumJoram Soch, Anni Richter, Jasmin M Kizilirmak, et al.
International Journal of Geriatric Psychiatry|October 6, 2023
Machine learning-based classification of Alzheimer's disease and its at-risk states using personality traits, anxiety, and depressionKonrad F Waschkies, Joram Soch, Margarita Darna, et al.
Nature Communications|April 17, 2026
Dysfunction of the episodic memory network in the Alzheimer's disease cascadeRené Lattmann, Niklas Vockert, Jose Bernal, et al.
Alzheimer'S Research & Therapy|November 24, 2021
Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer's diseaseMartin Dyrba, Moritz Hanzig, Slawek Altenstein, et al.
Brain Communications|February 10, 2025
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrumLena Haag, Elisa Lancini, Renat Yakupov, et al.
Brain : a Journal of Neurology|October 26, 2022
Cholinergic white matter pathways along the Alzheimer's disease continuumMilan Nemy, Martin Dyrba, Frederic Brosseron, et al.
Alzheimer'S Research & Therapy|May 24, 2023
Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional studyJose Bernal, Stefanie Schreiber, Inga Menze, et al.
Molecular Psychiatry|April 17, 2025
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s diseaseDavid Mengel, Ester Soter, Julia Maren Ott, et al.
Pageof 40